Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Revenue: 2011-2024

Historic Revenue for Ptc Therapeutics (PTCT) over the last 14 years, with Dec 2024 value amounting to $806.8 million.

  • Ptc Therapeutics' Revenue rose 7.23% to $211.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 95.40%. This contributed to the annual value of $806.8 million for FY2024, which is 13.97% down from last year.
  • Latest data reveals that Ptc Therapeutics reported Revenue of $806.8 million as of FY2024, which was down 13.97% from $937.8 million recorded in FY2023.
  • Over the past 5 years, Ptc Therapeutics' Revenue peaked at $937.8 million during FY2023, and registered a low of $380.8 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $806.8 million (2024), whereas its average is $814.5 million.
  • Per our database at Business Quant, Ptc Therapeutics' Revenue surged by 41.45% in 2021 and then declined by 13.97% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Revenue (Yearly) stood at $380.8 million in 2020, then skyrocketed by 41.45% to $538.6 million in 2021, then increased by 29.75% to $698.8 million in 2022, then surged by 34.20% to $937.8 million in 2023, then fell by 13.97% to $806.8 million in 2024.